Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Remimazolam + alfentanil for sedation during gastrointestinal endoscopy
ChiCTR2000041551Phase 4Recruiting
- Sponsor
- The First Affiliated Hospital of Zhengzhou University
- Start
- Jan 2021
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, open-label, single-arm trial of remimazolam and alfentanil in Central nervous system dysfunction, Procedural anxiety and procedural pain, sponsored by The First Affiliated Hospital of Zhengzhou University. Primary endpoint: Sedation success rate. Started Jan 2021; status: recruiting.
02
Drugs
remimazolamalfentanil
03
Conditions
Central nervous system dysfunctionProcedural anxietyprocedural pain
Beyond the preview
Go deeper on ChiCTR2000041551.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR2000041551.